Free Trial
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free HTGMQ Stock Alerts

HTG Molecular Diagnostics (HTGMQ) Competitors

Compare

HTGMQ vs. OLITW, PRENW, QSIAW, SMAPW, and TT

Should you buy HTG Molecular Diagnostics stock or one of its competitors? MarketBeat compares HTG Molecular Diagnostics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with HTG Molecular Diagnostics include OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), and Trane Technologies (TT). These companies are all part of the "measuring and control equipment" industry.

How does HTG Molecular Diagnostics compare to OmniLit Acquisition?

OmniLit Acquisition (NASDAQ:OLITW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both measuring and control equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings, media sentiment and risk.

OmniLit Acquisition has higher earnings, but lower revenue than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OmniLit AcquisitionN/AN/AN/AN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A

Company Net Margins Return on Equity Return on Assets
OmniLit AcquisitionN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

In the previous week, OmniLit Acquisition's average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.

Company Overall Sentiment
OmniLit Acquisition Neutral
HTG Molecular Diagnostics Neutral

Summary

HTG Molecular Diagnostics beats OmniLit Acquisition on 1 of the 1 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to Prenetics Global?

Prenetics Global (NASDAQ:PRENW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
Prenetics GlobalN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

In the previous week, Prenetics Global's average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.

Company Overall Sentiment
Prenetics Global Neutral
HTG Molecular Diagnostics Neutral

Prenetics Global has higher revenue and earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prenetics Global$92.39MN/AN/AN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A

Summary

Prenetics Global beats HTG Molecular Diagnostics on 1 of the 1 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to Quantum-Si?

Quantum-Si (NASDAQ:QSIAW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, earnings, valuation and risk.

Quantum-Si has higher earnings, but lower revenue than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quantum-Si$1.85MN/AN/AN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A

Company Net Margins Return on Equity Return on Assets
Quantum-SiN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

In the previous week, Quantum-Si's average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.

Company Overall Sentiment
Quantum-Si Neutral
HTG Molecular Diagnostics Neutral

Summary

HTG Molecular Diagnostics beats Quantum-Si on 1 of the 1 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to SportsMap Tech Acquisition?

HTG Molecular Diagnostics (NASDAQ:HTGMQ) and SportsMap Tech Acquisition (NASDAQ:SMAPW) are both measuring and control equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends, media sentiment and institutional ownership.

Company Net Margins Return on Equity Return on Assets
HTG Molecular DiagnosticsN/A N/A N/A
SportsMap Tech Acquisition N/A N/A N/A

In the previous week, HTG Molecular Diagnostics' average media sentiment score of 0.00 equaled SportsMap Tech Acquisition'saverage media sentiment score.

Company Overall Sentiment
HTG Molecular Diagnostics Neutral
SportsMap Tech Acquisition Neutral

SportsMap Tech Acquisition has lower revenue, but higher earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A
SportsMap Tech AcquisitionN/AN/AN/AN/AN/A

Summary

HTG Molecular Diagnostics beats SportsMap Tech Acquisition on 1 of the 1 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to Trane Technologies?

Trane Technologies (NYSE:TT) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both measuring and control equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability and analyst recommendations.

Trane Technologies currently has a consensus price target of $506.56, indicating a potential upside of 12.18%. Given Trane Technologies' stronger consensus rating and higher possible upside, equities analysts clearly believe Trane Technologies is more favorable than HTG Molecular Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Trane Technologies
1 Sell rating(s)
6 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.61
HTG Molecular Diagnostics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Trane Technologies has a beta of 1.25, suggesting that its stock price is 25% more volatile than the broader market. Comparatively, HTG Molecular Diagnostics has a beta of 3.25, suggesting that its stock price is 225% more volatile than the broader market.

Trane Technologies has higher revenue and earnings than HTG Molecular Diagnostics. HTG Molecular Diagnostics is trading at a lower price-to-earnings ratio than Trane Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trane Technologies$21.32B4.68$2.92B$12.9334.92
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A

Trane Technologies has a net margin of 13.41% compared to HTG Molecular Diagnostics' net margin of 0.00%. Trane Technologies' return on equity of 35.55% beat HTG Molecular Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
Trane Technologies13.41% 35.55% 13.73%
HTG Molecular Diagnostics N/A N/A N/A

In the previous week, Trane Technologies had 22 more articles in the media than HTG Molecular Diagnostics. MarketBeat recorded 22 mentions for Trane Technologies and 0 mentions for HTG Molecular Diagnostics. Trane Technologies' average media sentiment score of 1.32 beat HTG Molecular Diagnostics' score of 0.00 indicating that Trane Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Trane Technologies Positive
HTG Molecular Diagnostics Neutral

83.0% of Trane Technologies shares are owned by institutional investors. 0.1% of Trane Technologies shares are owned by insiders. Comparatively, 2.6% of HTG Molecular Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Trane Technologies beats HTG Molecular Diagnostics on 14 of the 16 factors compared between the two stocks.

Get HTG Molecular Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HTGMQ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HTGMQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HTGMQ vs. The Competition

Export
MetricHTG Molecular DiagnosticsAnalytical instruments IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2K$6.46B$12.34B
Dividend YieldN/AN/A2.76%5.28%
P/E Ratio0.00N/A21.0025.66
Price / SalesN/A0.00558.1986.31
Price / CashN/AN/A43.4956.67
Price / BookN/A0.0110.407.14
Net Income-$21.59M-$47.72M$3.57B$335.98M

HTG Molecular Diagnostics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37MN/A90
OLITW
OmniLit Acquisition
N/A$1.08
+20.0%		N/A+2,306.9%$0.00N/AN/A3
PRENW
Prenetics Global
N/A$0.02
-10.1%		N/A+6.2%$0.00$92.39MN/A1
QSIAW
Quantum-Si
N/A$0.03
-7.4%		N/A-96.1%$0.00$1.85MN/A150
SMAPW
SportsMap Tech Acquisition
N/A$0.02
-23.2%		N/A-44.0%$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:HTGMQ) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...
Eagle Publishing | Sponsoredtc pixel
The S-1 just dropped. 22 days left.
The SpaceX S-1 is now public - $18.7 billion in revenue, a $75 billion raise, and a June 12 Nasdaq listing con...
Behind the Markets | Sponsoredtc pixel
My crisis of conscience
Emmet Savage - named in Irish America's Wall Street 50 as one of the most successful investors in the world - ...
Porter & Company | Sponsoredtc pixel
Your book attached
Bill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...
Profits Run | Sponsoredtc pixel
Opportunity Forming in a U.S. Supply-Chain Weak Spot?
America has a supply-chain problem with graphite - demand is climbing while dependence on foreign sources rema...
i2i Marketing Group, LLC | Sponsoredtc pixel
Skip the Line Opportunity: The SpaceX IPO
Former tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...
Brownstone Research | Sponsoredtc pixel